Gene expression analyses revealed that, given its high expression among cancers studied and consistent overexpression in most AML patients, PIWIL4 could be a potential vulnerability that could be exploited as a therapeutic target in AML (Bamezai et al., 2023). The gene discussed is PIWIL4; the disease is cancer.